Pre-treatment with AMB or BQ788, and particularly BOS, resulted in a marked blockade of the ET-1-mediated up-regulation of Col1 and FN (Fig. 3), underscoring the involvement of both receptors. Here, FN1 is linked to Buschke-Ollendorff syndrome.